0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-SCD1 Antibody Market Research Report 2026
Published Date: 2026-03-24
|
Report Code: QYRE-Auto-20S17822
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti SCD1 Antibody Market Research Report 2024
BUY CHAPTERS

Global Anti-SCD1 Antibody Market Research Report 2026

Code: QYRE-Auto-20S17822
Report
2026-03-24
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Anti-SCD1 Antibody Market

The global Anti-SCD1 Antibody market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Anti-SCD1 Antibody competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Anti-SCD1 antibody is a kind of antibody that specifically targets and binds to Stearoyl-CoA desaturase 1 (SCD1), a key enzyme involved in lipid metabolism, typically used in research settings to study the role of SCD1 in various biological processes.
The North American market for Anti-SCD1 Antibody is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Anti-SCD1 Antibody is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Anti-SCD1 Antibody include Abcam, Bioss, Bethyl Laboratories, HUABIO, Biorbyt, Santa Cruz Biotechnology, LSBio, OriGene Technologies, Thermo Fisher Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Anti-SCD1 Antibody market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-SCD1 Antibody. The Anti-SCD1 Antibody market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-SCD1 Antibody market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-SCD1 Antibody manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Anti-SCD1 Antibody Market Report

Report Metric Details
Report Name Anti-SCD1 Antibody Market
Segment by Type
  • Monoclonal Anti-SCD1 Antibody
  • Polyclonal Anti-SCD1 Antibody
by Application
  • Co-Immunoprecipitation
  • Western Blot
  • Immunofluorescence
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abcam, Bioss, Bethyl Laboratories, HUABIO, Biorbyt, Santa Cruz Biotechnology, LSBio, OriGene Technologies, Thermo Fisher Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Anti-SCD1 Antibody manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Anti-SCD1 Antibody sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-SCD1 Antibody Market report?

Ans: The main players in the Anti-SCD1 Antibody Market are Abcam, Bioss, Bethyl Laboratories, HUABIO, Biorbyt, Santa Cruz Biotechnology, LSBio, OriGene Technologies, Thermo Fisher Scientific

What are the Application segmentation covered in the Anti-SCD1 Antibody Market report?

Ans: The Applications covered in the Anti-SCD1 Antibody Market report are Co-Immunoprecipitation, Western Blot, Immunofluorescence, Others

What are the Type segmentation covered in the Anti-SCD1 Antibody Market report?

Ans: The Types covered in the Anti-SCD1 Antibody Market report are Monoclonal Anti-SCD1 Antibody, Polyclonal Anti-SCD1 Antibody

1 Anti-SCD1 Antibody Market Overview
1.1 Product Definition
1.2 Anti-SCD1 Antibody by Type
1.2.1 Global Anti-SCD1 Antibody Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Anti-SCD1 Antibody
1.2.3 Polyclonal Anti-SCD1 Antibody
1.3 Anti-SCD1 Antibody by Application
1.3.1 Global Anti-SCD1 Antibody Market Value by Application: 2025 vs 2032
1.3.2 Co-Immunoprecipitation
1.3.3 Western Blot
1.3.4 Immunofluorescence
1.3.5 Others
1.4 Global Anti-SCD1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-SCD1 Antibody Revenue 2021–2032
1.4.2 Global Anti-SCD1 Antibody Sales 2021–2032
1.4.3 Global Anti-SCD1 Antibody Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Anti-SCD1 Antibody Market Competition by Manufacturers
2.1 Global Anti-SCD1 Antibody Sales Market Share by Manufacturers (2021–2026)
2.2 Global Anti-SCD1 Antibody Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Anti-SCD1 Antibody Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Anti-SCD1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Anti-SCD1 Antibody, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Anti-SCD1 Antibody, Product Types and Applications
2.7 Global Key Manufacturers of Anti-SCD1 Antibody, Date of Entry into the Industry
2.8 Global Anti-SCD1 Antibody Market Competitive Situation and Trends
2.8.1 Global Anti-SCD1 Antibody Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Anti-SCD1 Antibody Players Market Share by Revenue
2.8.3 Global Anti-SCD1 Antibody Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti-SCD1 Antibody Market Scenario by Region
3.1 Global Anti-SCD1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Anti-SCD1 Antibody Sales by Region: 2021–2032
3.2.1 Global Anti-SCD1 Antibody Sales by Region: 2021–2026
3.2.2 Global Anti-SCD1 Antibody Sales by Region: 2027–2032
3.3 Global Anti-SCD1 Antibody Revenue by Region: 2021–2032
3.3.1 Global Anti-SCD1 Antibody Revenue by Region: 2021–2026
3.3.2 Global Anti-SCD1 Antibody Revenue by Region: 2027–2032
3.4 North America Anti-SCD1 Antibody Market Facts & Figures by Country
3.4.1 North America Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Anti-SCD1 Antibody Sales by Country (2021–2032)
3.4.3 North America Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-SCD1 Antibody Market Facts & Figures by Country
3.5.1 Europe Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Anti-SCD1 Antibody Sales by Country (2021–2032)
3.5.3 Europe Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-SCD1 Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Anti-SCD1 Antibody Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Anti-SCD1 Antibody Sales by Region (2021–2032)
3.6.3 Asia Pacific Anti-SCD1 Antibody Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Anti-SCD1 Antibody Market Facts & Figures by Country
3.7.1 Latin America Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Anti-SCD1 Antibody Sales by Country (2021–2032)
3.7.3 Latin America Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Anti-SCD1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-SCD1 Antibody Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Anti-SCD1 Antibody Sales by Country (2021–2032)
3.8.3 Middle East and Africa Anti-SCD1 Antibody Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-SCD1 Antibody Sales by Type (2021–2032)
4.1.1 Global Anti-SCD1 Antibody Sales by Type (2021–2026)
4.1.2 Global Anti-SCD1 Antibody Sales by Type (2027–2032)
4.1.3 Global Anti-SCD1 Antibody Sales Market Share by Type (2021–2032)
4.2 Global Anti-SCD1 Antibody Revenue by Type (2021–2032)
4.2.1 Global Anti-SCD1 Antibody Revenue by Type (2021–2026)
4.2.2 Global Anti-SCD1 Antibody Revenue by Type (2027–2032)
4.2.3 Global Anti-SCD1 Antibody Revenue Market Share by Type (2021–2032)
4.3 Global Anti-SCD1 Antibody Price by Type (2021–2032)
5 Segment by Application
5.1 Global Anti-SCD1 Antibody Sales by Application (2021–2032)
5.1.1 Global Anti-SCD1 Antibody Sales by Application (2021–2026)
5.1.2 Global Anti-SCD1 Antibody Sales by Application (2027–2032)
5.1.3 Global Anti-SCD1 Antibody Sales Market Share by Application (2021–2032)
5.2 Global Anti-SCD1 Antibody Revenue by Application (2021–2032)
5.2.1 Global Anti-SCD1 Antibody Revenue by Application (2021–2026)
5.2.2 Global Anti-SCD1 Antibody Revenue by Application (2027–2032)
5.2.3 Global Anti-SCD1 Antibody Revenue Market Share by Application (2021–2032)
5.3 Global Anti-SCD1 Antibody Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Company Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abcam Anti-SCD1 Antibody Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 Bioss
6.2.1 Bioss Company Information
6.2.2 Bioss Description and Business Overview
6.2.3 Bioss Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bioss Anti-SCD1 Antibody Product Portfolio
6.2.5 Bioss Recent Developments/Updates
6.3 Bethyl Laboratories
6.3.1 Bethyl Laboratories Company Information
6.3.2 Bethyl Laboratories Description and Business Overview
6.3.3 Bethyl Laboratories Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bethyl Laboratories Anti-SCD1 Antibody Product Portfolio
6.3.5 Bethyl Laboratories Recent Developments/Updates
6.4 HUABIO
6.4.1 HUABIO Company Information
6.4.2 HUABIO Description and Business Overview
6.4.3 HUABIO Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 HUABIO Anti-SCD1 Antibody Product Portfolio
6.4.5 HUABIO Recent Developments/Updates
6.5 Biorbyt
6.5.1 Biorbyt Company Information
6.5.2 Biorbyt Description and Business Overview
6.5.3 Biorbyt Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biorbyt Anti-SCD1 Antibody Product Portfolio
6.5.5 Biorbyt Recent Developments/Updates
6.6 Santa Cruz Biotechnology
6.6.1 Santa Cruz Biotechnology Company Information
6.6.2 Santa Cruz Biotechnology Description and Business Overview
6.6.3 Santa Cruz Biotechnology Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Santa Cruz Biotechnology Anti-SCD1 Antibody Product Portfolio
6.6.5 Santa Cruz Biotechnology Recent Developments/Updates
6.7 LSBio
6.7.1 LSBio Company Information
6.7.2 LSBio Description and Business Overview
6.7.3 LSBio Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 LSBio Anti-SCD1 Antibody Product Portfolio
6.7.5 LSBio Recent Developments/Updates
6.8 OriGene Technologies
6.8.1 OriGene Technologies Company Information
6.8.2 OriGene Technologies Description and Business Overview
6.8.3 OriGene Technologies Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 OriGene Technologies Anti-SCD1 Antibody Product Portfolio
6.8.5 OriGene Technologies Recent Developments/Updates
6.9 Thermo Fisher Scientific
6.9.1 Thermo Fisher Scientific Company Information
6.9.2 Thermo Fisher Scientific Description and Business Overview
6.9.3 Thermo Fisher Scientific Anti-SCD1 Antibody Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Thermo Fisher Scientific Anti-SCD1 Antibody Product Portfolio
6.9.5 Thermo Fisher Scientific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-SCD1 Antibody Industry Chain Analysis
7.2 Anti-SCD1 Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-SCD1 Antibody Production Mode & Process Analysis
7.4 Anti-SCD1 Antibody Sales and Marketing
7.4.1 Anti-SCD1 Antibody Sales Channels
7.4.2 Anti-SCD1 Antibody Distributors
7.5 Anti-SCD1 Antibody Customer Analysis
8 Anti-SCD1 Antibody Market Dynamics
8.1 Anti-SCD1 Antibody Industry Trends
8.2 Anti-SCD1 Antibody Market Drivers
8.3 Anti-SCD1 Antibody Market Challenges
8.4 Anti-SCD1 Antibody Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Anti-SCD1 Antibody Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Anti-SCD1 Antibody Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Anti-SCD1 Antibody Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Anti-SCD1 Antibody Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Anti-SCD1 Antibody Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Anti-SCD1 Antibody Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Anti-SCD1 Antibody Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Anti-SCD1 Antibody Average Price (US$/g) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Anti-SCD1 Antibody, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Anti-SCD1 Antibody, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Anti-SCD1 Antibody, Product Types and Applications
 Table 12. Global Key Manufacturers of Anti-SCD1 Antibody, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti-SCD1 Antibody Companies by Tier (Tier 1, Tier 2, Tier 3), based on Anti-SCD1 Antibody Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti-SCD1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Anti-SCD1 Antibody Sales by Region (kg), 2021–2026
 Table 18. Global Anti-SCD1 Antibody Sales Market Share by Region (2021–2026)
 Table 19. Global Anti-SCD1 Antibody Sales by Region (kg), 2027–2032
 Table 20. Global Anti-SCD1 Antibody Sales Market Share by Region (2027–2032)
 Table 21. Global Anti-SCD1 Antibody Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Anti-SCD1 Antibody Revenue Market Share by Region (2021–2026)
 Table 23. Global Anti-SCD1 Antibody Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Anti-SCD1 Antibody Revenue Market Share by Region (2027–2032)
 Table 25. North America Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
 Table 27. North America Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
 Table 28. North America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
 Table 32. Europe Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
 Table 33. Europe Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Anti-SCD1 Antibody Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Anti-SCD1 Antibody Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Anti-SCD1 Antibody Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Anti-SCD1 Antibody Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Anti-SCD1 Antibody Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
 Table 42. Latin America Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
 Table 43. Latin America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Anti-SCD1 Antibody Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Anti-SCD1 Antibody Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Anti-SCD1 Antibody Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Anti-SCD1 Antibody Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Anti-SCD1 Antibody Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Anti-SCD1 Antibody Sales (kg) by Type (2021–2026)
 Table 51. Global Anti-SCD1 Antibody Sales (kg) by Type (2027–2032)
 Table 52. Global Anti-SCD1 Antibody Sales Market Share by Type (2021–2026)
 Table 53. Global Anti-SCD1 Antibody Sales Market Share by Type (2027–2032)
 Table 54. Global Anti-SCD1 Antibody Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Anti-SCD1 Antibody Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Anti-SCD1 Antibody Revenue Market Share by Type (2021–2026)
 Table 57. Global Anti-SCD1 Antibody Revenue Market Share by Type (2027–2032)
 Table 58. Global Anti-SCD1 Antibody Price (US$/g) by Type (2021–2026)
 Table 59. Global Anti-SCD1 Antibody Price (US$/g) by Type (2027–2032)
 Table 60. Global Anti-SCD1 Antibody Sales (kg) by Application (2021–2026)
 Table 61. Global Anti-SCD1 Antibody Sales (kg) by Application (2027–2032)
 Table 62. Global Anti-SCD1 Antibody Sales Market Share by Application (2021–2026)
 Table 63. Global Anti-SCD1 Antibody Sales Market Share by Application (2027–2032)
 Table 64. Global Anti-SCD1 Antibody Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Anti-SCD1 Antibody Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Anti-SCD1 Antibody Revenue Market Share by Application (2021–2026)
 Table 67. Global Anti-SCD1 Antibody Revenue Market Share by Application (2027–2032)
 Table 68. Global Anti-SCD1 Antibody Price (US$/g) by Application (2021–2026)
 Table 69. Global Anti-SCD1 Antibody Price (US$/g) by Application (2027–2032)
 Table 70. Abcam Company Information
 Table 71. Abcam Description and Business Overview
 Table 72. Abcam Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 73. Abcam Anti-SCD1 Antibody Product
 Table 74. Abcam Recent Developments/Updates
 Table 75. Bioss Company Information
 Table 76. Bioss Description and Business Overview
 Table 77. Bioss Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 78. Bioss Anti-SCD1 Antibody Product
 Table 79. Bioss Recent Developments/Updates
 Table 80. Bethyl Laboratories Company Information
 Table 81. Bethyl Laboratories Description and Business Overview
 Table 82. Bethyl Laboratories Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 83. Bethyl Laboratories Anti-SCD1 Antibody Product
 Table 84. Bethyl Laboratories Recent Developments/Updates
 Table 85. HUABIO Company Information
 Table 86. HUABIO Description and Business Overview
 Table 87. HUABIO Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 88. HUABIO Anti-SCD1 Antibody Product
 Table 89. HUABIO Recent Developments/Updates
 Table 90. Biorbyt Company Information
 Table 91. Biorbyt Description and Business Overview
 Table 92. Biorbyt Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 93. Biorbyt Anti-SCD1 Antibody Product
 Table 94. Biorbyt Recent Developments/Updates
 Table 95. Santa Cruz Biotechnology Company Information
 Table 96. Santa Cruz Biotechnology Description and Business Overview
 Table 97. Santa Cruz Biotechnology Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 98. Santa Cruz Biotechnology Anti-SCD1 Antibody Product
 Table 99. Santa Cruz Biotechnology Recent Developments/Updates
 Table 100. LSBio Company Information
 Table 101. LSBio Description and Business Overview
 Table 102. LSBio Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 103. LSBio Anti-SCD1 Antibody Product
 Table 104. LSBio Recent Developments/Updates
 Table 105. OriGene Technologies Company Information
 Table 106. OriGene Technologies Description and Business Overview
 Table 107. OriGene Technologies Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 108. OriGene Technologies Anti-SCD1 Antibody Product
 Table 109. OriGene Technologies Recent Developments/Updates
 Table 110. Thermo Fisher Scientific Company Information
 Table 111. Thermo Fisher Scientific Description and Business Overview
 Table 112. Thermo Fisher Scientific Anti-SCD1 Antibody Sales (kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
 Table 113. Thermo Fisher Scientific Anti-SCD1 Antibody Product
 Table 114. Thermo Fisher Scientific Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Anti-SCD1 Antibody Distributors List
 Table 118. Anti-SCD1 Antibody Customers List
 Table 119. Anti-SCD1 Antibody Market Trends
 Table 120. Anti-SCD1 Antibody Market Drivers
 Table 121. Anti-SCD1 Antibody Market Challenges
 Table 122. Anti-SCD1 Antibody Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti-SCD1 Antibody
 Figure 2. Global Anti-SCD1 Antibody Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Anti-SCD1 Antibody Market Share by Type: 2025 & 2032
 Figure 4. Monoclonal Anti-SCD1 Antibody Product Picture
 Figure 5. Polyclonal Anti-SCD1 Antibody Product Picture
 Figure 6. Global Anti-SCD1 Antibody Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Anti-SCD1 Antibody Market Share by Application: 2025 & 2032
 Figure 8. Co-Immunoprecipitation
 Figure 9. Western Blot
 Figure 10. Immunofluorescence
 Figure 11. Others
 Figure 12. Global Anti-SCD1 Antibody Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Anti-SCD1 Antibody Market Size (US$ Million), 2021–2032
 Figure 14. Global Anti-SCD1 Antibody Sales (kg), 2021–2032
 Figure 15. Global Anti-SCD1 Antibody Average Price (US$/g), 2021–2032
 Figure 16. Anti-SCD1 Antibody Report Years Considered
 Figure 17. Anti-SCD1 Antibody Sales Share by Manufacturers in 2025
 Figure 18. Global Anti-SCD1 Antibody Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Anti-SCD1 Antibody Players: Market Share by Revenue in Anti-SCD1 Antibody in 2025
 Figure 20. Anti-SCD1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Anti-SCD1 Antibody Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
 Figure 23. North America Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 24. United States Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
 Figure 27. Europe Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Anti-SCD1 Antibody Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Anti-SCD1 Antibody Revenue Market Share by Region (2021–2032)
 Figure 35. China Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Anti-SCD1 Antibody Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Anti-SCD1 Antibody Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Anti-SCD1 Antibody Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Anti-SCD1 Antibody by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Anti-SCD1 Antibody by Type (2021–2032)
 Figure 55. Global Anti-SCD1 Antibody Price (US$/g) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Anti-SCD1 Antibody by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Anti-SCD1 Antibody by Application (2021–2032)
 Figure 58. Global Anti-SCD1 Antibody Price (US$/g) by Application (2021–2032)
 Figure 59. Anti-SCD1 Antibody Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI